Penn Capital Management Company, LLC Bausch Health Companies Inc. Transaction History

Penn Capital Management Company, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$7.06 - $23.63 $766,257 - $2.56 Million	-108,535 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$21.6 - $27.79 $48,211 - $62,027	2,232 Added 2.1%	108,535 $2.53 Million
Q4 2021 Feb 17, 2022	SELL	$23.0 - $29.01 $82,570 - $104,145	-3,590 Reduced 3.27%	106,303 $2.94 Million
Q3 2021 Nov 15, 2021	SELL	$25.04 - $30.06 $27,518 - $33,035	-1,099 Reduced 0.99%	109,893 $3.06 Million
Q2 2021 Aug 16, 2021	BUY	$27.43 - $32.7 $725,057 - $864,359	26,433 Added 31.26%	110,992 $3.25 Million
Q1 2021 May 13, 2021	BUY	$21.37 - $34.38 $10,172 - $16,364	476 Added 0.57%	84,559 $2.68 Million
Q4 2020 Feb 16, 2021	BUY	$15.31 - $21.12 $1.29 Million - $1.78 Million	84,083 New	84,083 $1.75 Million

256

255M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.69B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Penn Capital Management Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Penn Capital Management Company, LLC with notifications on news.